Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The purpose of this study is to evaluate the safety and immunogenicity of a single subcutaneous injection of TAK-850 as compared to intramuscular injection of TAK-850 in healthy Japanese adults
Epistemonikos ID: 9d3ea6d50ce38672200b0d05a14e17e1f5357168
First added on: May 12, 2024